Jetzt bei Plus500 CFDs auf die weltweit gefragtesten Basiswerte wie Aktien, Indizes oder Kryptowährungen entdecken!5 -W-
16.03.2017 13:00:00

Encompass Compliance Corporation (ENCC) and Madison Avenue Drug Testing Sign a Channel Sales Agreement

CHARLOTTE, North Carolina, March 16, 2017 /PRNewswire/ --

Encompass Compliance Corp. (OTC PINK:ENCC) announces a channel sales agreement with Madison Avenue Drug Testing.

Encompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our solutions provide organizations with up-to-date policies, a comprehensive resource center and real-time monitoring for drug and alcohol testing orders.

Madison Avenue Drug Testing (http://madisonavenueproducts.com) is a premier provider of drug testing products to corporations throughout the U.S. They provide products that test for: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine, ecstasy, methadone, buprenorphine, barbiturates, ketamine, K2, tramadol, ETG. "As a supplier of drug testing products to over 3,000 companies, they are a natural fit to provide our Risk Shield Compliance services to their customers," says Encompass CEO, Richard Sharp.

Madison Avenue Drug Testing CEO Keith Devine says, "We feel extremely fortunate to be selected by Encompass Inc. as a channel partner. Combining the best legal minds in the business with our diverse clientele, instills confidence in our customers that they are provided the most comprehensive state specific compliance solutions available."

There will be joint marketing activities such as webinars, regular mailings and updates on a regular basis to Madison Avenue Drug Testing Customers.

Safe Harbor Statement:

This press release may include predictions, estimates, opinions or statements that might be considered "forward-looking" under the provisions of the Private Securities Litigation Reform Act of 1995. Statements generally identified by phrases such as the Company or its management "believes," "expects," "forecasts," "estimates," or other words or phrases are forward-looking.


For further information, contact:
Richard Sharp
866-328-7487
admin@encompinc.com
https://www.encompinc.com/

SOURCE Encompass Compliance Corp.

Nachrichten zu Trailblazer Resources Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Trailblazer Resources Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!